Engaging consumers in their health care takes many forms. One is encouraging them to understand the cost of services better and to consider shopping among providers on the basis of price and quality. One such effort, in regard to magnetic resonance imaging (MRI) services is explored in a study published in Health Affairs. (HA Article) Health care services are notorious for the difficulty of identifying a specific price for a specific service. While it is well-known that there is wide variation in price across providers, a single provider may have multiple prices for the same service, depending on the payer. The patient’s benefit plan may also affect what the patient perceives as the price–what matter’s to the patient is what it costs him or her. And, most importantly, patients vary widely in their economic and health sophistication. Many patients either actually aren’t capable of absorbing information and making a good decision, or lack confidence in their ability to do so. MRI services lend themselves to relatively easy price comparisons, so it is a good category to test. Some past research suggests that just giving consumers price data doesn’t result in more use of less expensive services. Where patients see some clear financial benefit, however, as in some reference pricing experiments, they do seem to respond by moving to lower-priced vendors. In the current research, claims data from several Blue Cross plans was examined to see the effect of an intensive program to provide consumers with price data on MRIs and to support their decision-making on which provider to use. Spending and use for members in these plans was compared with a control group that weren’t covered by a price transparency effort. On an adjusted basis, the cost of a test decreased $95 for the intervention group, while increasing $124 for the control group. One primary factor was less use of hospital-based MRIs, and more use of freestanding MRI facilities. It also appeared that as a result of this shift, in the later years of the intervention, hospital-based facilities reduced their prices. The research shows that at least for a relatively simple service like an MRI, it is possible to lower spending by giving patients relevant information and supporting their decision-making, particularly if the patients have a financial stake in the decision.
Price Transparency and Competition
By Kevin RocheAugust 28, 2014Commentary
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
Another example of over-priced companies trying to find some way to survive in the post-epidemic financial world. Transcarent, which does something, somehow to “access high quality, affordable care” is buying...
March 6, 2023
In an attempt to swiftly revive two floundering health care companies, a PE firm has announced the merger and recapitalization of Revive Health and SwiftMD. You know they are...
January 30, 2023
Investors have not yet learned their lesson, as Pearl Health gathers a new round of $75 million in capital for its business of supporting physicians who want to participate in...
January 30, 2023
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace
March 27, 2023
Why You Can’t Trust People Who Make Up Stuff About Vax Safety
A couple of studies offer a far better explanation for heart issues in athletes and…
March 25, 2023
Coronamonomania Lives Forever, Part 201
Tired of March Madness? A boringly refreshing dip into some CV-19 research summaries is recommended.
March 24, 2023
The CDC Is a Font of Methodological and Statistical Error
Several times in the last three years I and others have pointed out serious flaws…